Jean Jacques Bienaime - May 20, 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
May 20, 2024
Transactions value $
-$92,614
Form type
4
Date filed
5/21/2024, 04:09 PM
Previous filing
May 13, 2024
Next filing
May 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Tax liability -$92.6K -1.2K -0.25% $77.05 474K May 20, 2024 Direct
holding BMRN Common Stock 247K May 20, 2024 Shares held by Jean-Jacques Bienaime Family Trust
holding BMRN Common Stock 100 May 20, 2024 Shares held as UTMA custodian for child 1
holding BMRN Common Stock 100 May 20, 2024 Shares held as UTMA custodian for child 2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jean Jacques Bienaime is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.